{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-21-011550","form_type":"8-K","ticker":"GTBP","cik":"0000109657","company_name":"GT Biopharma, Inc.","filed_at":"2021-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.476992+00:00","generated_at":"2026-06-28T15:36:06.378116+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"GT Biopharma files 8-K to announce updated corporate presentation on website; no specifics disclosed","bullets":["Filing states corporate presentation as of Nov 1, 2021 was posted to company website.","Presentation filed as Exhibit 99.1 but full content not provided in filing text.","No financial results, guidance, or operational changes mentioned in the filing.","Ticker: GTBP; common stock listed on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-21-011550","json":"https://secwatch.observer/filing/0001654954-21-011550.json","markdown":"https://secwatch.observer/filing/0001654954-21-011550.md","text":"https://secwatch.observer/filing/0001654954-21-011550.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/109657/000165495421011550/0001654954-21-011550-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/109657/000165495421011550/gtbp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T15:36:06.378116+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}